29 March, 2017 - News
Stockholm (HedgeNordic) – In an interview with Bloomberg, Henrik Rhenman (pictured) who manages the 460 million-euro Rhenman Healthcare Equity L/S Fund, praises his Scientific Advisory Board and highlights the importance of asking clinical expertise before investing in complex Products.